MORTON COLLINS Insider Trading $GEB INOVIO PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MORTON COLLINS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MORTON COLLINS. MORTON COLLINS is Director in SPECIAL DIVERSIFIED OPPORTUNITIES INC. ($SDOI) and Director in KOPIN CORP ($KOPN) and Director in INOVIO PHARMACEUTICALS, INC. ($GEB).
MORTON COLLINS in INOVIO PHARMACEUTICALS, INC.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of MORTON COLLINS: Director
Holdings: 168,130 shares
Latest Transaction: May 13 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MORTON COLLINS in INOVIO PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GEB, KOPN, SDOI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2019 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | M | 0.00 | 8,170 | 0 | 0 | |
| May 13 2019 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | M | 0.00 | 8,170 | 0 | 168,130 | 160 K to 168.1 K (+5.11 %) |
| May 09 2019 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 0.00 | 8,013 | 0 | 8,013 | |
| May 09 2019 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 3.90 | 12,500 | 48,750 | 12,500 | |
| May 14 2018 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | M | 0.00 | 7,669 | 0 | 0 | |
| May 14 2018 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 0.00 | 8,170 | 0 | 8,170 | |
| May 14 2018 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 4.56 | 12,500 | 57,000 | 12,500 | |
| May 14 2018 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | M | 0.00 | 7,669 | 0 | 159,960 | 152.3 K to 160 K (+5.04 %) |
| May 15 2017 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| May 15 2017 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 7.14 | 12,500 | 89,250 | 12,500 | |
| May 15 2017 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 0.00 | 7,669 | 0 | 7,669 | |
| May 15 2017 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | M | 0.00 | 10,000 | 0 | 152,291 | 142.3 K to 152.3 K (+7.03 %) |
| Mar 28 2017 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 6.25 | 21,300 | 133,189 | 50,000 | 28.7 K to 50 K (+74.22 %) |
| Jun 29 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 9.13 | 10,000 | 91,309 | 142,291 | 132.3 K to 142.3 K (+7.56 %) |
| Jun 29 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 9.13 | 10,000 | 91,309 | 142,291 | 132.3 K to 142.3 K (+7.56 %) |
| May 16 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 9.33 | 10,000 | 93,300 | 10,000 | |
| May 16 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| May 09 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
| May 09 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | M | 0.00 | 5,000 | 0 | 132,291 | 127.3 K to 132.3 K (+3.93 %) |
| Apr 18 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 9.49 | 28,000 | 265,700 | 64,750 | 36.8 K to 64.8 K (+76.19 %) |
| Apr 18 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 9.57 | 28,000 | 267,960 | 64,750 | 36.8 K to 64.8 K (+76.19 %) |
| Apr 18 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 9.46 | 4,200 | 39,720 | 6,650 | 2.5 K to 6.7 K (+171.43 %) |
| Apr 18 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 9.49 | 2,000 | 18,979 | 6,450 | 4.5 K to 6.5 K (+44.94 %) |
| Apr 18 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 9.45 | 6,200 | 58,565 | 28,700 | 22.5 K to 28.7 K (+27.56 %) |
| May 08 2015 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 8.01 | 7,500 | 60,075 | 7,500 | |
| May 08 2015 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 |
Page: 1